BioXcel Therapeutics (BTAI) Shares Outstanding (2017 - 2026)

BioXcel Therapeutics' Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $12.2 million for Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 381.58% year-over-year to $12.2 million in Q4 2025; TTM through Dec 2025 was $12.2 million, a 381.58% increase from a year earlier, with the FY2025 full-year figure at $12.2 million, up 381.58% from the prior year.
• Shares Outstanding (Entity) improved to $12.2 million in Q4 2025 per BTAI's latest filing, from $6.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $12.2 million in Q4 2025 and bottomed at $1.5 million in Q1 2021.
• The 5-year median for Shares Outstanding (Entity) is $1.8 million (2023), against an average of $2.9 million.
• Across the five-year window, Shares Outstanding (Entity) climbed 0.15% in 2022 and jumped 381.58% in 2025, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $1.7 million in 2021, then gained by 0.6% to $1.8 million in 2022, then climbed by 6.33% to $1.9 million in 2023, then soared by 35.52% to $2.5 million in 2024, then soared by 381.58% to $12.2 million in 2025.
• Per Business Quant, the three latest BTAI Shares Outstanding (Entity) figures stand at $12.2 million (Q4 2025), $6.6 million (Q2 2025), and $5.5 million (Q1 2025).